Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V with the active ingredient mycophenolic acid in the dosage form PSE. - 5436

World Biggest Tenders Source

This tender with title Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V with the active ingredient mycophenolic acid in the dosage form PSE. - 5436 has been published on Bidding Source portal dated 12 Jan 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V with the active ingredient mycophenolic acid in the dosage form PSE. - 5436

Tender Type :

Invitation for Bids

Country :

Germany

Publish Date :

12 Jan 2025

Closing Date :

10 Nov 2026

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical discount agreements from 01.03.2025 for various active ingredients within the framework of an open-house procedure - 17478 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient iron carboxymaltose (ATC code: B03AC01). - 13808 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient epinephrine (ATC code: C01CA24). - 13626 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient combination of brinzolamide and timolol (ATC: S01ED67). - 12266 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 7510 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 9802 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient mepolizumab (ATC code: R03DX09). - 9971 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active substances mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 798173 Germany Pharmaceutical products – Open House discount contracts 2024-14 - 791163 Germany Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V in the period from 01.01.2025 - 30.06.2026 - 784579 Germany

Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V with the active ingredient mycophenolic acid in the dosage form PSE. - 5436

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com